Skip to content
healthcare.dev

Neostigmine Methylsulfate

NDC 23155-518, Neostigmine Methylsulfate, injection, from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..

Product NDC
23155-518
Status
Listed
Labeler
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208230
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/23155-518 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
23155-518-412315505184110 VIAL in 1 CARTON (23155-518-41) / 10 mL in 1 VIAL (23155-518-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9cc2bfa1-c968-4d01-8162-2ef188974164

Use it

Look up 23155-518 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/23155-518 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 23155-518. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.